Stobadine: Bellwether of a broader view of drug actions

Life Sciences

Volumn 65, Issue 18-19, 1999, Pages 1857-1864

  Vincenzi, Frank F ^a,b   Hinds, Thomas R ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Oxygen radical absorbance capacity, ORAC; Pramipexole; Stobadine; Tirilazad

Indexed keywords

ANTIOXIDANT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FREE RADICAL; LIPID; OXYGEN RADICAL; PHYCOERYTHRIN; PRAMIPEXOLE; STOBADINE; TIRILAZAD; WATER;

AGING; ANTIOXIDANT ACTIVITY; AREA UNDER THE CURVE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ABSORPTION; DRUG MARKETING; DRUG MECHANISM; DRUG RECEPTOR BINDING; FLUORESCENCE; HUMAN; HYDROPHILICITY; HYDROPHOBICITY; PARKINSON DISEASE; REACTION TIME; STRUCTURE ACTIVITY RELATION;

ANTIOXIDANTS; CARBOLINES; FREE RADICAL SCAVENGERS; PHYCOERYTHRIN; WATER;

EID: 0033212902     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00438-5     Document Type: Conference Paper

References (53)

1. S. Stolc and L. Horáková, New Trends in Clinical Neuropharmacology, D. Bartko, P. Turĉani and G. Stern (eds), 59-63, John LIbbey & Co., London (1988).
2. L. Benes and S. Stolc, Drugs of the Future 14 135-137 (1989).
3. L. Horáková, L. Lukovic and S. Stolc, Pharmazie 45 223-224 (1990).
4. L. Horáková, V. Uraaz, O. Ondrejicková, L. Lukovic and I. Juránek, Biomed. Biochim. Acta 50 1019-1025 (1991).
5. A. Stasko, K. Ondrias, V. Misik, H. Szöcsová and D. Gergel, Chem. Papers 44 493-500 (1990).
6. M. Stefek and L. Benes, FEBS Lett. 294 264-266 (1991).
7. K.A. Clinch, F.F. Vincenzi, T.T. Rohn and T.R. Hinds, Proc. West. Pharmacol. Soc. 36 209-214 (1993).
8. H.J. Schatzmann, Experientia 22 364-365 (1966).
9. H.J. Schatzmann and F.F. Vincenzi, J. Physiol. (Lond. ) 201 369-385 (1969).
10. G. Cao, H.M. Alessio and R.G. Cutler, Free Radic. Biol. Med. 14 303-311 (1993).
11. F.P. Carrea, E.J. Lesnefsky, D.G. Kaiser and L.D. Horwitz, J. Cardiovasc. Pharmacol. 20 230-235 (1992).
12. E.D. Hall, Ann. Neurol. 32 S137-S142 (1992).
13. J.A. Clemens, R.D. Saunders, P.P. Ho, L.A. Phebus and J.A. Panetta, Stroke 24 716-723 (1993).
14. D. Offen, I. Ziv, H. Sternin, E. Melamed and A. Hochman, Exp. Neurol. 141 32-39 (1996).
15. V. Udupi and C. Rice-Evans, Free Radic. Res. Commun. 16 315-323 (1992).
16. N. Kaul, N. Siveski-Iliskovic, M. Hill, N. Khaper, C. Seneviratne and P.K. Singal, Mol. Cell. Biochem. 161 283-288 (1996).
17. M. Kuzuya and F. Kuzuya, Free Radic. Biol. Med. 14 67-77 (1993).
18. S.J.T. Mao, M.T. Yates, A.E. Rechtin, R.L. Jackson and W.A. Van Sickle, J. Med. Chem. 34 298-302 (1991).
19. C.E. Cross, B. Halliwell, E.T. Borish, W.A. Pryor, B.N. Ames, R.L. Saul, J.M. McCord and D. Harman, Ann. Intern. Med. 107 526-545 (1987).
20. B. Halliwell and C.E. Cross, Environ. Health Perspect. 102 Suppl. 10 5-12 (1994).
21. T. Yoshikawa, Eur. Neurol. 33 Suppl. 1 60-68 (1993).
22. T. Yoshikawa, Y. Minamiyama, Y. Naito and M. Kondo, J. Neurochem. 62 1034-1038 (1994).
23. W.B. Weglicki and I.T. Mak, Mol. Cell. Biochem. 118 105-111 (1992).
24. M. Ishida, T. Ishida, H. Matsuura, R. Ozono, G. Kajiyama and T. Oshima, Am. J. Physiol. Regul. Integr. Comp. Physiol. 267 R1288-R1293 (1994).
25. W.F. Kauder and J.A. Watts, Biochem. Pharmacol. 51 811-819 (1996).
26. I. Karmansky and N. Gruener, Clin. Chim. Acta 259 177-182 (1997 ).
27. P. Lesnik, C. Dachet, L. Petit, M. Moreau, S. Griglio, P. Brudi and M.J. Chapman, Arterioscler. Thromb. Vasc. Biol. 17 979-988 (1997).
28. T.-L. Yue, P.J. McKenna, P.G. Lysko, R.R. Ruffolo,Jr. and G.Z. Feuerstein, Atherosclerosis 97 209-216(1992).
29. T.-L. Yue, P.J. McKenna, R.R. Ruffolo,Jr. and G. Feuerstein, Eur. J. Pharmacol. 214 277-280 (1992).
30. T.L. Yue, PJ. McKenna, J.L. Gu, H.Y. Cheng, R.R. Ruffolo,Jr. and G.Z. Feuerstein, Hypertension 22 922-928 (1993).
31. M. Chopra, J. McMurray, H.J. Dargie and W.E. Smith, Free Radic. Biol. Med. 9, Suppl 1 151 (1990).(Abstract)
32. G.J. Westerveld, R.A. Scheeren, I. Dekker, D.H. Griffioen, H.P. Voss and A. Bast, Eur. J. Pharmacol. Mol. Pharmacol. 291 27-31 (1995).
33. L. Iuliano, J.Z. Pedersen, G. Rotilio, D. Ferro and F. Violi, Free Radic. Biol. Med. 18 239-247 (1995).
34. R.-M. Wu, C.C. Chiueh, A. Pert and D.L. Murphy, Eur. J. Pharmacol. 243 241-247 (1993).
35. T.R. Green, S.R. Bennett and V.M. Nelson, Toxicol. Appl. Pharmacol. 129 163-169 (1994).
36. J.B.A. Custódio, T.C.P. Dinis, L.M. Almeida and V.M.C. Madeira, Biochem. Pharmacol. 47 1989-1998 (1994).
37. S. Parthasarathy, A.J. Morales and A.A. Murphy, J. Clin. Invest. 94 1990-1995 (1994).
38. D.M. Hockenbery, Z.N. Oltvai, X.-M. Yin, C.L. Milliman and S.J. Korsmeyer, Cell 75 241-251 (1993).
39. P. Raschke, P. Massoudy and B.F. Becker, Free Radic. Biol. Med. 19 461-471 (1995).
40. R.J. Reiter, B. Poeggeler, D.-X. Tan, L.-D. Chen, L.C. Manchester and J.M. Guerrero, Neuroendocrinol. Lett. 15 103-116 (1993).
41. K.-A. Marshall, R.J. Reiter, B. Poeggeler, O.I. Aruoma and B. Halliwell, Free Radic. Biol. Med. 21 307-315 (1996).
42. G. Deliconstantinos, V. Villiotou and J.C. Stavrides, Anticancer Res. 16 2969-2979 (1996).
43. J.M. Carney and A.M. Carney, Life Sci. 55 2097-2103 (1994).
44. P.F. Good, P. Werner, A. Hsu, C.W. Olanow and D.P. Perl, Am. J. Pathol. 149 21-28 (1996).
45. N.R. Sims, Neurodegeneration 5 435-440 (1996).
46. W.R. Markesbery, Free Radic. Biol. Med. 23 134-147 (1997).
47. T.G. Hastings, D.A. Lewis and M.J. Zigmond, Adv. Exp. Med. Biol. 387 97-106
48. J.W. Miller, J. Selhub and J.A. Joseph, Free Radic. Biol. Med. 21 241-249 (1996).
49. P. Jenner and C.W. Olanow, Neurology 47 Suppl. 3 S161-S170 (1996).
50. J.P.E. Spencer, A. Jenner, J. Butler, O.I. Aruoma, D.T. Dexter, P. Jenner and B. Halliwell, Free Radic. Res. 24 95-105 (1996).
51. E.D. Hall, P.K. Andrus, J.A. Oostveen, J.S. Althaus and P.F. Vonvoigtlander, Brain Res. 742 80-88 (1996).
52. D. Harman, Proc. Natl. Acad. Sci. USA 78 7124-7128 (1981).
53. D. Harman, Age 17 119-146 (1994).